The HIV latency reversing agent HODHBt inhibits the phosphatases PTPN1 and PTPN2. [PDF]
Howard JN +12 more
europepmc +1 more source
A high-throughput, microplate reader-based method to monitor in vitro HIV latency reversal in the absence of flow cytometry. [PDF]
Nkwelle CE +9 more
europepmc +1 more source
The sounds of silencing: dynamic epigenetic control of HIV latency. [PDF]
Nguyen K, Karn J.
europepmc +1 more source
Editorial: HIV Latency: novel insights into the viral reservoir and therapeutic strategies. [PDF]
de Oliveira ACS, Abreu CM.
europepmc +1 more source
A First-in-Class Dual Degrader of Bcl-2/Bcl-xL Reverses HIV Latency and Minimizes Ex Vivo Reservoirs from Patients. [PDF]
Chang LC +5 more
europepmc +1 more source
Three novel epigenetic-modifying compounds identified as HIV latency-reversing agents in Ghana
Abana CZ +13 more
europepmc +1 more source
SARS-CoV-2 Modulation of HIV Latency Reversal in a Myeloid Cell Line: Direct and Bystander Effects. [PDF]
Jarmoluk P +7 more
europepmc +1 more source
A macrophage-cell model of HIV latency reveals the unusual importance of the bromodomain axis. [PDF]
Kisaka JK, Rauch D, Griffith M, Kyei GB.
europepmc +1 more source
Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells. [PDF]
Dimapasoc M +8 more
europepmc +1 more source
Integrated Single-cell Multiomic Analysis of HIV Latency Reversal Reveals Novel Regulators of Viral Reactivation. [PDF]
Ashokkumar M +11 more
europepmc +1 more source

